Department of Otology, Neurotology and Skull Base Surgery, Gruppo Otologico, Piacenza-Rome, Italy.
Otol Neurotol. 2018 Dec;39(10):e1026-e1033. doi: 10.1097/MAO.0000000000001972.
External auditory canal cholesteatomas (EACC) is insidious in nature and rare entity. There are only few case series on EACCs and surgical strategy is not standardized.
Retrospective study in a quaternary referral center of 31 consecutive cases of EACC.
Thirty-one patients with EACC were reviewed. Unilateral otorrhea 19 (61.2%), hearing loss 22 (70.9%), and otalgia 8 (25.8%) are cardinal symptoms. Sixteen primary and 15 secondary EACCs were treated. Bone erosion was observed in 20 cases. In the present series, stage III = 12 (38.7%), stage II = 8 (25.8%), stage I = 11 (35.4%) underwent definitive treatment by surgery. Canalplasty with reconstruction was done in 19 cases of stages I and II. Of 12 cases in stage III, 3 cases underwent canalplasty with reconstruction. Subtotal petrosectomy was done in five cases. Intact canal wall mastoidectomy with canalplasty in two cases and radical mastoidectomy in two cases. Fascia, cartilage, muscle, and bone dust were used for reconstruction. Median follow-up period was 6 years and no recurrence of cholesteatoma was observed.
EACC is unique entity. Intraoperative and radiological findings assist in correct and practical staging of EACC. Late stage presentations of EACC are common. Definitive surgical treatment in our series avoided recurrence of cholesteatoma.
外耳道胆脂瘤(EACC)性质隐匿,较为罕见。目前仅有少数关于 EACC 的病例系列研究,且手术策略尚未标准化。
1)阐明 EACC 的病因和主要特征。2)提出一种实用的 EACC 分期方法。3)根据 EACC 的分期列举手术治疗方法。
在一家四级转诊中心对 31 例 EACC 连续病例进行回顾性研究。
共回顾了 31 例 EACC 患者。单侧耳漏 19 例(61.2%)、听力损失 22 例(70.9%)和耳痛 8 例(25.8%)是主要症状。16 例原发性和 15 例继发性 EACC 得到治疗。20 例患者存在骨质侵蚀。在本研究中,III 期 12 例(38.7%)、II 期 8 例(25.8%)、I 期 11 例(35.4%)患者接受了确定性手术治疗。19 例 I 期和 II 期患者行外耳道成形术和重建术。12 例 III 期患者中,3 例行外耳道成形术和重建术。5 例行部分颞骨切除术,2 例行保留外耳道全厚皮瓣的乳突切除术,2 例行根治性乳突切除术。使用筋膜、软骨、肌肉和骨屑进行重建。中位随访时间为 6 年,未观察到胆脂瘤复发。
EACC 是一种独特的疾病。术中及影像学表现有助于 EACC 的正确和实用分期。EACC 的晚期表现较为常见。本研究中采用的确定性手术治疗方法可避免胆脂瘤复发。